Navigation Links
Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008
Date:4/9/2009

CHICAGO, April 9 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare Solutions, Inc. ("Allscripts") announced today information related to the federal income tax treatment of the special dividend of $5.23 per share distributed in connection with the transactions Allscripts consummated with Misys plc on October 10, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

At the time of the special dividend, Allscripts disclosed that in general the special dividend would be taxable as a dividend to the extent of current and accumulated earnings and profits of legacy Allscripts Healthcare Solutions, Inc. through December 31, 2008, but that the amount of such earnings and profits could not be determined until after the end of 2008. Allscripts has now completed its review of Allscripts earnings and profits and has determined that, of the special cash dividend of $5.23 per share, the first 10.28%, or approximately $0.54 per share, is taxable as a dividend. Thereafter, the special cash dividend will generally be treated as a tax-free return of capital that reduces a stockholder's tax basis in its shares of Allscripts common stock to the extent of such tax basis and, after such basis has been reduced to zero, taxable as gain from the sale or exchange of Allscripts common stock. As required by applicable regulations, the special cash dividend had previously been reported on IRS Form 1099 as being entirely taxable. Amended IRS Forms 1099 to reflect this final tax treatment will be distributed.

The tax treatment of the special cash dividend will depend on the individual circumstances of each stockholder and stockholders are urged to seek advice from their tax advisor. For additional information on the tax treatment of the special cash dividend, you may refer to the section of the definitive proxy statement filed by Allscripts with the Securities and Exchange Commission on August 21, 2008 entitled "Material U.S. Federal Income Tax Consequences of the Transactions" beginning on page 64 of such proxy statement.

About Allscripts

Allscripts (Nasdaq: MDRX) uses innovation technology to bring health to healthcare. More than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health record, electronic prescribing, revenue cycle management, practice management, document management, medication services, hospital care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.


'/>"/>
SOURCE Allscripts
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
2. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
3. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
4. Allscripts Featured in Microsoft HealthVault Worldwide Launch
5. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
6. Allscripts to Announce Third Quarter 2007 Results on November 8th
7. Allscripts Reports Third Quarter 2007 Results
8. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
9. Allscripts Adds TeamPraxis Quality Reporting Software for Electronic Health Records
10. ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers
11. Mankato Clinic Selects Allscripts Electronic Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: